Cable Hill Partners’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-19,258
| Closed | -$274K | – | 256 |
|
|
2024
Q3 | $274K | Buy |
19,258
+1,531
| +9% | +$21.8K | 0.03% | 172 |
|
|
2024
Q2 | $235K | Buy |
+17,727
| New | +$235K | 0.03% | 183 |
|
|
2023
Q4 | – | Sell |
-25,466
| Closed | -$394K | – | 224 |
|
|
2023
Q3 | $394K | Buy |
25,466
+5,178
| +26% | +$80.1K | 0.05% | 93 |
|
|
2023
Q2 | $326K | Sell |
20,288
-2,976
| -13% | -$47.8K | 0.04% | 121 |
|
|
2023
Q1 | $383K | Buy |
23,264
+3,617
| +18% | +$59.6K | 0.06% | 104 |
|
|
2022
Q4 | $306K | Buy |
+19,647
| New | +$306K | 0.05% | 128 |
|